Skip to main content
PMC home page
Brain Pathology logoLink to Brain Pathology
. 2008 Jun 28;7(1):681–693. doi: 10.1111/j.1750-3639.1997.tb01083.x

Neurocysticercosis

José E H Pittella 1,✉
PMCID: PMC8098197  PMID: 9034574

Abstract

Cysticercosis is an infection caused by Taenia solium larvae (cysticerci). When the cysticercus is lodged in the central nervous system (CNS), the disease is known as neurocysticercosis (NCC). NCC is the most frequent and most widely disseminated human neuroparasitosis. It is endemic in many parts of the world, particularly Latin America, Africa, and Asia, and still relatively frequent in Portugal, Spain and Eastern European countries. It is also endemic in developed countries with high rates of immigration from endemic areas. Man may act as an intermediate host after ingestion of mature, viable T. solium eggs via the fecal‐oral route. The development of lesions in the brain and leptomeninges, and the consequent onset of symptoms associated with NCC are mainly due to the host immune‐inflammatory response. As long as the cysticercus remains viable, there is relative host immune tolerance. It is only when the parasite dies that massive antigen exposure occurs, with intensification of the immune response/inflammatory reaction and the appearance or worsening of symptoms. NCC can be asymptomatic or cause widely varied clinical manifestations, such as seizures, increased intracranial pressure, ischemic cerebrovascular disease, dementia, and signs of compression of the spinal roots/cord. The combination of two or more symptoms is common. Such clinical polymorphism is determined by 1) the number of lesions (single or multiple cysticerci); 2) the location of CNS lesions (subarachnoid, intracerebral, intraventricular, intramedullary); 3) the type of cysticercus (Cysticercus cellulosae, Cysticercus racemosus); 4) the stage of development and involution of the parasite (vesicular or viable, necrotic, fibrocalcified nodule); and 5) the intensity of the host immune‐inflammatory response (no inflammatory reaction, leptomeningitis, encephalitis, granular ependymitis, arteritis).

Full Text

The Full Text of this article is available as a PDF (8.6 MB).

References

  • 1. Ahuja GK, Roy S., Kamla G., Virmani V. (1978) Cerebral cysticercosis. J Neurol Sci 35: 365–374. [DOI] [PubMed] [Google Scholar]
  • 2. Alarcón F., Hidalgo F., Moncayo J., Vian I., Dueas G. (1992) Cerebral cysticercosis and stroke. Stroke 23: 224–228. [DOI] [PubMed] [Google Scholar]
  • 3. Aluja AS (1982) Frequency of porcine cysticercosis in Mexico. In: Cysticercosis: Present State of Knowledge and Perspectives, Flisser A., Willms K., Laclette JP, Larralde C., Ridaura C., Beltrán F. (eds.), pp. 53–62, Academic Press: New York . [Google Scholar]
  • 4. Baily GG, Mason PR, Trijissenar EJ, Lyons NF (1988) Serological diagnosis of neurocysticercosis: evaluation of ELISA tests using cyst fluid and other components of Taenia solium cysticerci as antigens. Trans R Soc Trop Med Hyg 82: 295–299. [DOI] [PubMed] [Google Scholar]
  • 5. Berman JD, Beaver PC, Cheever AW, Quindlen EA (1981) Cysticercus of 60‐milliliter volume in human brain. Am J Trop Med Hyg 30: 616–619. [DOI] [PubMed] [Google Scholar]
  • 6. Bloom BR (1979) Games parasites play: how parasites evade immune surveillance. Nature 279: 21–26. [DOI] [PubMed] [Google Scholar]
  • 7. Botero D., Uribe CS, Sanchez JL, Alzate T., Velasquez G., Ocampo NE Villa LA (1993) Short course albendazole treatment for neurocysticercosis in Columbia. Trans R Soc Trop Med Hyg 87: 576–577. [DOI] [PubMed] [Google Scholar]
  • 8. Canelas HM, Ricciardi‐Cruz O., Escalante OAD (1963) Cysticercosis of the nervous system: less frequent clinical forms. III ‐ Spinal cord forms. Arq Neuro-Psiquiatr 21: 77–86. [DOI] [PubMed] [Google Scholar]
  • 9. Cheng TC (1986) General Parasitology, 2nd ed., Academic Press: Orlando , Florida . [Google Scholar]
  • 10. Chitwood M., Lichtenfels JR (1972) Identification of parasitic metazoa in tissue sections. Exp Parasitol 32: 407–519. [DOI] [PubMed] [Google Scholar]
  • 11. Colli BO, Assirati‐Junior JA, Machado HR, Santos F., Takayanagui OM (1994) Cysticercosis of the central nervous system. II. Spinal cysticercosis. Arq Neuro-Psiquiatr 52: 187–199. [DOI] [PubMed] [Google Scholar]
  • 12. Colli BO, Martelli N., Assirati‐Junior JA, Machado HR, Salvarani CP, Sassoli VP, Forjaz SV (1994) Cysticercosis of the central nervous system. I. Surgical treatment of cerebral cysticercosis: a 23 years experience in the Hospital das Clinicas of Ribeiro Preto Medical School. Arq Neuro-Psiquiatr 52: 166–186. [DOI] [PubMed] [Google Scholar]
  • 13. Corona T., Pascoe D., González‐Barranco D., Abad P., Landa L., Estaol B. (1986) Anticysticercous antibodies in serum and cerebrospinal fluid in patients with cerebral cysticercosis. J Neurol Neurosurg Psychiatry 49: 1044–1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Correa D., Gorodezky C., Castro L., Rabiela MT, Flisser A. (1986) Detection of MHC products on the surface of Taenia solium cysticerci from humans. Rev Latinoam Microbiol 28: 363–371. [PubMed] [Google Scholar]
  • 15. Creasy JL, Alarcón JJ (1994) Magnetic resonance imaging of neurocysticercosis. Top Magn Reson Imaging 6: 59–68. [PubMed] [Google Scholar]
  • 16. Davis LE, Kornfeld M. (1991) Neurocysticercosis: neurologic, pathogenic, diagnostic and therapeutic aspects. Eur Neurol 31: 229–240. [DOI] [PubMed] [Google Scholar]
  • 17. Del Brutto OH (1992) Cysticercosis and cerebrovascular disease: a review. J Neurol Neurosurg Psychiatry 55: 252–254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Del Brutto OH (1994) Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Neurology 44: 1706–1709. [DOI] [PubMed] [Google Scholar]
  • 19. Del Brutto OH (1995) Single parenchymal brain cysticercus in the acute encephalitic phase: definition of a distinct form of neurocysticercosis with a benign prognosis. J Neurol Neurosurg Psychiatry 58: 247–249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Del Brutto OH, García E., Talámas O., Sotelo J. (1988) Sex‐related severity of inflammation in parenchymal brain cysticercosis. Arch Intern Med 148: 544–546. [DOI] [PubMed] [Google Scholar]
  • 21. Del Brutto OH, Granados G., Talámas O., Sotelo J., Gorodezky C. (1991) Genetic pattern of the HLA system: HLA A, B, C, DR, and DQ antigens in Mexican patients with parenchymal brain cysticercosis. Hum Biol 63: 85–93. [PubMed] [Google Scholar]
  • 22. Del Brutto OH, Santibaez R., Noboa CA, Auirre R., Díaz E., Alarcón TA (1992) Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 42: 389–392. [DOI] [PubMed] [Google Scholar]
  • 23. Del Brutto OH, Sotelo J. (1988) Neurocysticercosis: an update. Rev Infect Dis 10: 1075–1087. [DOI] [PubMed] [Google Scholar]
  • 24. Diaz‐Camacho S., Candil‐Ruiz A., Uribe‐Beltran M., Willms K. (1990) Serology as an indicator of Taenia solium tapeworm infections in a rural community in Mexico. Trans R Soc Trop Med Hyg 84: 563–566. [DOI] [PubMed] [Google Scholar]
  • 25. Diwan AR, Coker‐Vann M., Brown P., Subianto DB, Yolken R., Desowitz R., Escobar A., Gibbs CC Jr, Gajdusek DC (1982) Enzyme‐linked immunosorbent assay (ELISA) for the detection of antibody to cysticerci of Taenia solium . Am J Trop Med Hyg 31: 364–369. [DOI] [PubMed] [Google Scholar]
  • 26. Escobar A. (1983) The pathology of neurocysticercosis. In: Cysticercosis of the Central Nervous System, Palacios E., Rodriguez‐Carbajal J., Taveras JM (eds.), pp. 27–54, Charles C Thomas: Springfield , Illinois . [Google Scholar]
  • 27. Escobar A., Nieto D. (1972) Parasitic diseases. In: Pathology of the Nervous System, Minckler J. (ed.), Vol. 3 pp. 2503–2521, McGraw‐Hill: New York . [Google Scholar]
  • 28. Espinoza B., Ruiz‐Palacios G., Tovar A., Sandoval MA, Plancarte A., Flisser A. (1986) Characterization by enzyme‐linked immunosorbent assay of the humoral immune response in patients with neurocysticercosis and its application in immunodiagnosis. J Clin Microbiol 24: 536–541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Estaol B., Corona T., Abad P. (1986) A prognostic classification of cerebral cysticercosis: therapeutic implications. J Neurol Neurosurg Psychiatry 49: 1131–1134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Estaol B., Juárez H., Irigoyen MC, González‐Barranco D., Corona T. (1989) Humoral immune response in patients with cerebral parenchymal cysticercosis treated with praziquantel. J Neurol Neurosurg Psychiatry 52: 254–257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Flisser A. (1988) Neurocysticercosis in Mexico. Parasitol Today 4: 131–137. [DOI] [PubMed] [Google Scholar]
  • 32. Flisser A., Gonzalez D., Plancarte A., Ostrosky P., Montero R., Stephano A., Correa D. (1990) Praziquantel treatment of brain and muscle porcine Taenia solium cysticercosis. 2. Immunological and cytogenetic studies. Parasitol Res 76: 640–642. [DOI] [PubMed] [Google Scholar]
  • 33. Flisser A., Madrazo I. (1996) Evagination of Taenia solium in the fourth ventricle. N Engl J Med 335: 753–754. [DOI] [PubMed] [Google Scholar]
  • 34. Flisser A., Pérez‐Montfort R., Larralde C. (1979) The immunology of human and animal cysticercosis: a review. Bull WHO 57: 839–856. [PMC free article] [PubMed] [Google Scholar]
  • 35. Garcia HH, Herera G., Gilman RH, Tsang VC, Pilcher JB Diaz JF, Candy EJ, Miranda E., Naranjo J. (1994) Discrepancies between cerebral computed tomography and western blot in the diagnosis of neurocysticercosis. The Cysticercosis Working Group in Peru (Clinical Studies Coordination Board). Am J Trop Med Hyg 50: 152–157. [DOI] [PubMed] [Google Scholar]
  • 36. Grisoa S., Wiedernolt WC (1982) CNS cysticercosis. Arch Neurol 39: 540–544. [DOI] [PubMed] [Google Scholar]
  • 37. Handler LC, Mervis B. (1983) Cerebral cysticercosis with reference to the natural history of parenchymal lesions. AJNR 4: 709–712. [PMC free article] [PubMed] [Google Scholar]
  • 38. Herrera LA, Santiago P., Rojas G., Salazar PM, Tato P., Mollnari JL, Schiffmann D., Ostrosky‐Wegman P. (1994) Immune response impairment, genotoxicity and morphological transformation induced by Taenia solium metacestode. Mutat Res 305: 223–228. [DOI] [PubMed] [Google Scholar]
  • 39. Isidro‐Llorens A., Dachs F., Vidal J., Sarrias M. (1993) Spinal cysticercosis. Case report and review. Paraplegia 31: 128–130. [DOI] [PubMed] [Google Scholar]
  • 40. Kibayashi K., Mastri AR, Hirsch CS (1996) Neuropathlogy of human immunodeficiency virus infection at different disease stages. Hum Pathol 27: 637–642. [DOI] [PubMed] [Google Scholar]
  • 41. Kramer LD, Locke GE, Byrd SE, Daryabagi J. (1989) Cerebral cysticercosis: documentation of natural history with CT. Radiology 171: 459–462. [DOI] [PubMed] [Google Scholar]
  • 42. Larralde C., Laclette JP, Owen CS, Madrazo I., Sandoval M., Bojalil R., Sciutto E., Contreras L., Arzate J., Diaz ML, Govezensky T., Montoya RM, Goodsaid F. (1986) Reliable sorology of Taenia solium cysticercosis with antigens from cyst vesicular fluid: Elisa and hemagglutination tests. Am J Trop Med Hyg 35: 965–973. [DOI] [PubMed] [Google Scholar]
  • 43. Levav M., Mirsky AF, Cruz ME, Cruz I. (1995) Neurocysticercosis and performance on neuropsychologic tests: a family study in Ecuador. Am J Trop Med Hyg 53: 552–557. [DOI] [PubMed] [Google Scholar]
  • 44. Levy AS, Lillehei KO, Rubinstein D., Stears JC (1995) Subarachnoid neurocysticercosis with, occlusion of the major intracranial arteries: case report. Neurosurgery 36: 183–188. [DOI] [PubMed] [Google Scholar]
  • 45. Lobato RD, Lamas E., Portillo JM, Roger R., Esparza J., Rivas JJ, Muoz MJ (1981) Hydrocephalus in cerebral cysticercosis. Pathogenic and therapeutic considerations. J Neurosurg 55: 786–793. [DOI] [PubMed] [Google Scholar]
  • 46. Lockwood DNJ, Weber JN (1989) Parasite infections in AIDS. Parasitol Today 5: 310–316. [DOI] [PubMed] [Google Scholar]
  • 47. Loyo M., Kleriga E., Estaol B. (1980) Fourth ventricular cysticercosis. Neurosurgery 7: 456–458. [DOI] [PubMed] [Google Scholar]
  • 48. McCormick GF, Zee C‐S, Heiden J. (1982) Cysticercosis cerebri. Review of 127 cases. Arch Neurol 39: 534–539. [DOI] [PubMed] [Google Scholar]
  • 49. Medina MT, Genton P., Montoya MC, Cordova S., Dravet C., Sotelo J. (1993) Effect of anticysticercal treatment on the prognosis of epilepsy in neurocysticercosis: a pilot trial. Epilepsia 34: 1024–1027. [DOI] [PubMed] [Google Scholar]
  • 50. Medina MT, Rosas E., Rubio‐Donnadieu F., Sotelo J. (1990) Neurocysticercosis as the main cause of late‐onset epilepsy in Mexico. Arch Intern Med 150: 325–327. [PubMed] [Google Scholar]
  • 51. Meeusen E., Barcham GJ, Gorrell MD, Rickard MD, Brandon MR (1990) Cysticercosis: cellular immune responses during primary and secondary infection. Parasite Immunol 12: 403–41852. [DOI] [PubMed] [Google Scholar]
  • 52. Mervis B., Lotz JW (1980) Compute parenchymal cerebral cysticercosis Clin Radiol 31: 521–528. [DOI] [PubMed] [Google Scholar]
  • 53. Moli JL, Tato P., Lara‐Agllera R., White AC Jr (1993) Effects of serum from neurocysticercosis patients on the structure and viability of Taenia solium . J Parasitol 79: 124–127. [PubMed] [Google Scholar]
  • 54. Monteiro L. Coe T., Stocker A. (1992) Neurocysticercosis ‐ A review of 231 cases. infection 20: 61–65. [DOI] [PubMed] [Google Scholar]
  • 55. Nasclmento E., Nogueira PMP, Tavares CAP (1987) Improved immunodiagnosis of human cysticercosis with scolex protein antigen. Parasitol Res 73: 446–450. [DOI] [PubMed] [Google Scholar]
  • 56. Nash TE, Neva FA (1984) Recent advances in the diagnosis and treatment of cerebral cysticercosis N Egl J Med 311: 1492–1496. [DOI] [PubMed] [Google Scholar]
  • 57. Orihel TC, Ash LR (1995) Parasites in Human Tissues. American Society of Clinical Pathologists: Chicago . [Google Scholar]
  • 58. Peters G. (1970) Klinsche Neuropathologie. Spezielle Pathologie der Krankheiten des zentralen und peripheren Nervensystems, 2. Auflage, Georg Thieme Verlag: Stuttgart . [Google Scholar]
  • 59. Plancarte A., Fexas M., Filsser A. (1994) Reactivity in ELISA and dot blot of purified GP24, an immunodominant antigen of Taenia solium, for the diagnosis of human neurocysticercosis. Int J Parasitol 24: 733–738. [DOI] [PubMed] [Google Scholar]
  • 60. Queiroz AC, Andrade‐Filho AS (1991) Estudo neuropatológieo de caso fatal tratado com praziante. Arq Neuro-Psiquiatr 49: 106–110. [DOI] [PubMed] [Google Scholar]
  • 61. Queiroz LS, Pellegrini‐Fho A., Calegaro D., Faria LL (1975) Intramedullary cysticercosis. Case report, literature review and comments on pathogenesis. J Neurol Sci 26: 61–70. [DOI] [PubMed] [Google Scholar]
  • 62. Rabiela‐Cervantes MT, Rivas‐Hernandez A., Cast ilo‐Medina S., Gonzalez‐Angulo A. (1985) Morphological evidence indicating that C. cellulosae and C. racemosus are larval stages of Taenia solium . Arch invest Med (Méx) 16: 81–92. [PubMed] [Google Scholar]
  • 63. Rabiela‐Cervantes MT, Rivas‐Hernández A., Rodriguez‐Ibarra J., Castillo‐Medina S., Cancino FM (1982) Anatomopathological aspects of human brain cysticercosis. In: Cysticercosis: Present State of Knowledge and Perspectives, Flisser A., Willms K., Laclette JP, Larralde C. (eds.), pp. 179–200, Academic Press: New York . [Google Scholar]
  • 64. Rajshekhar V. (1993) Albendazole therapy for persistent, solitary cysticercus granulomas in patients with seizures. Neurology 43: 1238–1240. [DOI] [PubMed] [Google Scholar]
  • 65. Rangel R., Torres B., Del Brutto O., Sot J. (1987) Cysticercotic encephalitis: a severe form in young females. Am J Trop Med Hyg 36: 387–392. [DOI] [PubMed] [Google Scholar]
  • 66. Redalié L. (1921) Deux cas de cysticercese céréprospinale avec méningite chronique et endartérite oblitérate cérébrale. Rev Neurol 28: 241–266. [Google Scholar]
  • 67. Ridaura‐Sanz C. (1987) Host response in childhood neurocysticercosis: some pathological aspects. Childs Nerv Syst 3: 206–207. [DOI] [PubMed] [Google Scholar]
  • 68. Rodacki MA, Detoni XA, Txeira WR, Boer VH, Olveira GG (1989) CT features of cellulosae and racemosus neurocysticercosis. J Comput Assist Tomogr 13: 1013–1016. [DOI] [PubMed] [Google Scholar]
  • 69. Rodríguez‐Carbajal J., Del Brutto OH, Penagos P., Huebe J., Escobar A. (1989) Occlusion of the middle cerebral artery due to cysticercotic angilits. Stroke 20: 1095–1099. [DOI] [PubMed] [Google Scholar]
  • 70. Rodriguez‐Carbajal J., Palacios F., Zee C‐S (1983) Neuroradiology of cysticercosis of the central nervous system. In: Cysticercosis of the Central Nervous System, Palacios E., Rodriguez‐Carbajal J., Taveras JM (eds.), pp. 101–143. Charles C Thomas: Springfield , Illinois . [Google Scholar]
  • 71. Rosas N., Sotelo J., Nieto D. (1986) ELISA in the diagnosis of neurocysticercosis. Arch Neurol 43: 353–356. [DOI] [PubMed] [Google Scholar]
  • 72. Sanchetee PC, Venkataraman S., Dhamija RM, Roy AK (1994) Albendazole therapy for neurocysticercosis. J Assoc Physicians India 42: 116–117. [PubMed] [Google Scholar]
  • 73. Sangla S., de Broucker T., Abgrail, Gauthier N. (1995) Infarctus cérébral révélateur d'une neurocysticercose. Rev Neurol 151: 277–280. [PubMed] [Google Scholar]
  • 74. Scaravilli F. (1992) Parasitic and fungal infections. In: Greenfield's Neuropathology, Adams JH, Duchen LW (eds.), pp. 400–446, 5th Edition, Oxford University Press: New York . [Google Scholar]
  • 75. Schantz PM (1989) Surveillance and control programs for cestode diseases. In: Parasitic Diseases: Treatment and Control, Miller MJ, Love EJ, (eds.), pp. 275–290, CRC Press: Boca Raton , Florida . [Google Scholar]
  • 76. Schantz PM, Moore AC, Muoz JL, Hartman BJ, Schaefer JA, Aron AM, Persaud D., Sarti E., Wilson M., Flisser A. (1992) Neurocysticercosis in an orthodox Jewish community in New York City. N Engl J Med 327: 692–695. [DOI] [PubMed] [Google Scholar]
  • 77. Scharf D. (1988) Neurocysticercosis. Two hundred thirty‐eight cases from a California hospital. Arch Neurol 45: 777–780. [DOI] [PubMed] [Google Scholar]
  • 78. Shankar SK, Ravi V., Suryanarayana V., Chandramukhi A., Ravikumar BV (1995) Immunoreactive antigenic sites of Cysticercus cellulosae relevant to human neurocysticercosis ‐ immunocytochemical localization using human CSF as source of antibody. Clin Neuropathol 14: 33–36. [PubMed] [Google Scholar]
  • 79. Silbert PL, Gubbay SS, Khangure M. (1993) Distinctive MRI findings in a case of neurocysticercosis. Med J Aust 159:185–186. [DOI] [PubMed] [Google Scholar]
  • 80. Sotelo J., Guerrero V., Rubio F. (1985) Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases. Arch Intern Med 145: 442–445. [PubMed] [Google Scholar]
  • 81. Sotelo J., Marin C. (1987) Hydrocephalus secondary to cysticercotic arachnoiditis. A long‐term follow‐up review of 92 cases. J Neurosurg 66: 686–689. [DOI] [PubMed] [Google Scholar]
  • 82. Sparks AK, Neafie RC, Connor DH (1976) Cysticercosis. In: Pathology of Tropical and Extraordinary Diseases, Binford CH, Connor DH (eds.), Vol. 2 pp. 539–543, Armed Forces Institute of Pathology: Washington , DC . [Google Scholar]
  • 83. Tavares AR Jr (1993) Psychiatric disorders in neurocysticercosis. Br J Psychiatry 163: 839. [DOI] [PubMed] [Google Scholar]
  • 84. Teitelbaum GP, Otto RJ, Lin M., Watanabe AT, Stull MA, Manz HJ, Bradley WG (1989) MR imaging of neurocysticercosis. AJNR 10: 709–718. [DOI] [PubMed] [Google Scholar]
  • 85. Thornton CA, Houston S., Latif MB (1992) Neurocysticercosis and human immunodeficiency virus infection. Arch Neurol 49: 963–965. [DOI] [PubMed] [Google Scholar]
  • 86. Trelles JO, Trelles L. (1978) Cysticercosis of the nervous system. In: Handbook of Clinical Neurology, Vinken PJ, Bruyn GW, (eds.), Vol. 35: 291–320, North Holland: Amsterdam . [Google Scholar]
  • 87. Vasquez V., Sotelo J. (1992) The course of seizures after treatment for cerebral cysticercosis. N Engl J Med 327: 696–701. [DOI] [PubMed] [Google Scholar]
  • 88. Wadia N., Desai S., Bhatt M. (1988) Disseminated cysticercosis. New observations, including CT scan findings and experience with treatment by praziquantel. Brain 111: 597–614. [DOI] [PubMed] [Google Scholar]
  • 89. White AC Jr, Dakik H., Diaz P. (1995) Asymptomatic neurocysticercosis in a patient with AIDS and cryptococcal meningitis. Am J Med 99: 101–102. [DOI] [PubMed] [Google Scholar]
  • 90. White AC Jr, Tato P., Molinari JL (1992) Host‐parasite interactions in Taenia solium cysticercosis. Infect Agents Dis 1: 185–193. [PubMed] [Google Scholar]
  • 91. Willms K. (1992) Cestodes (Tapeworms). In: Infectious Diseases, Gorbach SL, Bartlett JG, Blacklow NR, (eds.), pp. 2021–2037, WB Saunders: Philadelphia . [Google Scholar]
  • 92. Zee CS, Segail HD, Destian S., Ahmadi J., Apuzzo ML (1993) MRI of intraventricular cysticercosis: surgical implications. J Comput Assist Tomogr 17: 932–939. [DOI] [PubMed] [Google Scholar]
  • 93. Zenteno‐Alanis GH (1982) A classification of human cysticercosis. In: Cysticercosis: Present State of Knowledge and Perspectives, Flisser A., Willms K., Laclette JP, Larralde C., Ridaura C., Beltrán F., (eds.), pp. 107–126, Academic Press: New York . [Google Scholar]
  • 94. Zhang YF, Li HW, Huang WC, Chu GR, Shi XW, Yin DL, Zhang JD, Wang XH, Zhou BL, Zhao D. (1993) Diagnosis and treatment of cysticercosis of cerebral ventricles. Chung-Kuo-Chi-Sheng-Chung Hsueh-Yu-Chi-Sheng-Chung-Ping-Tsa-Chih 11: 255–257. [PubMed] [Google Scholar]
  • 95. Zini D., Farrell VJR, Wadee AA (1990) The relationship of antibody levels to the clinical spectrum of human neurocysticercosis. J Neurol Neurosurg Psychiatry 53: 656–661. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES